October 2017 Briefing – Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for October 2017. This roundup includes the...
October 2017 Briefing – Geriatrics
Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for October 2017. This roundup includes the latest...
October 2017 Briefing – Cosmetic Surgery
Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for October 2017. This roundup includes the...
October 2017 Briefing – Anesthesiology
Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for October 2017. This roundup includes the latest...
October 2017 Briefing – Nephrology
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for October 2017. This roundup includes the latest...
October 2017 Briefing – Radiology
Here are what the editors at HealthDay consider to be the most important developments in Radiology for October 2017. This roundup includes the latest...
October 2017 Briefing – Pathology
Here are what the editors at HealthDay consider to be the most important developments in Pathology for October 2017. This roundup includes the latest...
October 2017 Briefing – Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for October 2017. This roundup includes the latest...
Calquence Approved for Mantle Cell Lymphoma
For patients who have not responded to at least one prior treatment or who have relapsed
Fentanyl or Analogs Tied to More Than Half of All Opioid Deaths
And 57 percent of fentanyl-related deaths also tested positive for other drugs, such as heroin
